These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11576716)

  • 1. Influence of age and comorbidities on the chemotherapeutic management of lung cancer.
    Deppermann KM
    Lung Cancer; 2001 Sep; 33 Suppl 1():S115-20. PubMed ID: 11576716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung cancer in the elderly: current and future chemotherapeutic options.
    Hinton S; Sandler A
    Drugs Aging; 2002; 19(5):365-75. PubMed ID: 12093323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recent topics in chemotherapy for elderly patients with lung cancer].
    Okamoto H; Watanabe K
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1097-104. PubMed ID: 10945002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current standards of care in small-cell and non-small-cell lung cancer.
    Schiller JH
    Oncology; 2001; 61 Suppl 1():3-13. PubMed ID: 11598409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do age and comorbidity impact treatment allocation and outcomes in limited stage small-cell lung cancer? a community-based population analysis.
    Ludbrook JJ; Truong PT; MacNeil MV; Lesperance M; Webber A; Joe H; Martins H; Lim J
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1321-30. PubMed ID: 12654444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panel.
    Gridelli C; Aapro M; Ardizzoni A; Balducci L; De Marinis F; Kelly K; Le Chevalier T; Manegold C; Perrone F; Rosell R; Shepherd F; De Petris L; Di Maio M; Langer C
    J Clin Oncol; 2005 May; 23(13):3125-37. PubMed ID: 15860872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical treatment of advanced non-small cell lung cancer in elderly patients: a review of the role of chemotherapy and targeted agents.
    Meoni G; Cecere FL; Lucherini E; Di Costanzo F
    J Geriatr Oncol; 2013 Jul; 4(3):282-90. PubMed ID: 24070465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of care survey (PCS) in lung cancer: how well does current U.S. practice with chemotherapy in the non-metastatic setting follow the literature?
    Langer CJ; Moughan J; Movsas B; Komaki R; Ettinger D; Owen J; Wilson JF
    Lung Cancer; 2005 Apr; 48(1):93-102. PubMed ID: 15777975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum albumin level as a potential marker for deciding chemotherapy or best supportive care in elderly, advanced non-small cell lung cancer patients with poor performance status.
    Ikeda S; Yoshioka H; Ikeo S; Morita M; Sone N; Niwa T; Nishiyama A; Yokoyama T; Sekine A; Ogura T; Ishida T
    BMC Cancer; 2017 Nov; 17(1):797. PubMed ID: 29183294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy in elderly patients with advanced lung cancer. Part I: General aspects and treatment of small cell lung cancer (SCLC).
    Honecker F; Wedding U; Bokemeyer C;
    Onkologie; 2004 Oct; 27(5):500-5. PubMed ID: 15585983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical effect of medroxyprogesterone (MPA) in elderly patients with lung cancer.
    Niiranen A; Kajanti M; Tammilehto L; Mattson K
    Am J Clin Oncol; 1990 Apr; 13(2):113-6. PubMed ID: 2156416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chemotherapy for lung cancer].
    Fujiwara K; Eguchi K
    Nihon Rinsho; 2000 May; 58(5):1087-92. PubMed ID: 10824554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of age on the treatment of limited-stage small-cell lung cancer.
    Siu LL; Shepherd FA; Murray N; Feld R; Pater J; Zee B
    J Clin Oncol; 1996 Mar; 14(3):821-8. PubMed ID: 8622030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lung cancer].
    Ono A; Yamamoto N
    Gan To Kagaku Ryoho; 2007 Mar; 34(3):367-73. PubMed ID: 17353626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Older age, poor performance status and major comorbidities: how to treat high-risk patients with advanced nonsmall cell lung cancer.
    Aggarwal C; Langer CJ
    Curr Opin Oncol; 2012 Mar; 24(2):130-6. PubMed ID: 22314616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of small cell lung cancer in the elderly.
    Shepherd FA; Amdemichael E; Evans WK; Chalvardjian P; Hogg-Johnson S; Coates R; Paul K
    J Am Geriatr Soc; 1994 Jan; 42(1):64-70. PubMed ID: 8277118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy for advanced non-small cell lung cancer: standards.
    Manegold C
    Lung Cancer; 2001 Dec; 34 Suppl 2():S165-70. PubMed ID: 11720760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evidence based chemotherapy for lung cancer].
    Watanabe H; Saijo N
    Gan To Kagaku Ryoho; 2000 Jan; 27(1):30-43. PubMed ID: 10660731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amrubicin monotherapy for elderly patients with previously treated lung cancer.
    Nakao M; Oguri T; Suzuki T; Kunii E; Tomita Y; Iwashima Y; Miyazaki M; Maeno K; Sato S; Ueda R
    Intern Med; 2010; 49(17):1857-62. PubMed ID: 20823645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of dose and dose intensity in lung cancer chemotherapy.
    Murray N
    Semin Oncol; 1987 Dec; 14(4 Suppl 4):20-8. PubMed ID: 2825357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.